Sign Out
Safety of SKYVaricella Inj. has not been evaluated in pregnant women. Direct and/or indirect adverse effect related to reproductive and developmental toxicity has not been observed in animal studies. However, SKYVaricella Inj. should not be administered to pregnant women since wild-type varicella (natural infection) is known to sometimes cause fetal harm. Furthermore, pregnancy should be avoided for 3 months following vaccination (refer to Contraindications).
It is not known whether live attenuated varicella virus is excreted in human milk. However, because some viruses are excreted in human milk, caution should be exercised if SKYVaricella Inj. is administered to nursing mothers.
Continue with Google